癌症治疗药物的药代动力学与能量平衡：饮食摄入、能量消耗和身体成分的作用。
Pharmacokinetics of cancer therapeutics and energy balance: the role of diet intake, energy expenditure, and body composition.
机构信息
Department of Medicine, Division of Endocrinology, University of British Columbia, Vancouver, Canada.
Irving K. Barber Faculty of Science, Department of Biology, University of British Columbia Okanagan, Kelowna, Canada.
出版信息
J Natl Cancer Inst Monogr. 2023 May 4;2023(61):3-11. doi: 10.1093/jncimonographs/lgad010.
Abstract
Energy balance accounts for an individual's energy intake, expenditure, and storage. Each aspect of energy balance has implications for the pharmacokinetics of cancer treatments and may impact an individual's drug exposure and subsequently its tolerance and efficacy. However, the integrated effects of diet, physical activity, and body composition on drug absorption, metabolism, distribution, and excretion are not yet fully understood. This review examines the existing literature on energy balance, specifically the role of dietary intake and nutritional status, physical activity and energy expenditure, and body composition on the pharmacokinetics of cancer therapeutics. As energy balance and pharmacokinetic factors can be influenced by age-related states of metabolism and comorbidities, this review also explores the age-related impact of body composition and physiologic changes on pharmacokinetics among pediatric and older adult populations with cancer.
摘要
能量平衡可解释为个体的能量摄入、消耗和储存。能量平衡的每一方面都对癌症治疗的药代动力学有影响，可能会影响个体的药物暴露，进而影响其耐受性和疗效。然而，饮食、体力活动和身体成分对药物吸收、代谢、分布和排泄的综合影响尚未完全被理解。这篇综述检查了关于能量平衡的现有文献，具体探讨了饮食摄入和营养状况、体力活动和能量消耗以及身体成分对癌症治疗药物药代动力学的作用。由于能量平衡和药代动力学因素可能受到与年龄相关的代谢状态和合并症的影响，本综述还探讨了身体成分和生理变化对儿科和老年癌症患者药代动力学的与年龄相关的影响。
相似文献
1
Pharmacokinetics of cancer therapeutics and energy balance: the role of diet intake, energy expenditure, and body composition.癌症治疗药物的药代动力学与能量平衡：饮食摄入、能量消耗和身体成分的作用。
J Natl Cancer Inst Monogr. 2023 May 4;2023(61):3-11. doi: 10.1093/jncimonographs/lgad010.
2
Dietary Intake and Energy Expenditure in Breast Cancer Survivors: A Review.乳腺癌幸存者的饮食摄入和能量消耗：综述。
Nutrients. 2021 Sep 27;13(10):3394. doi: 10.3390/nu13103394.
3
Energy balance components in persons with paraplegia: daily variation and appropriate measurement duration.截瘫患者的能量平衡组成部分：每日变化及合适的测量时长。
Int J Behav Nutr Phys Act. 2017 Sep 26;14(1):132. doi: 10.1186/s12966-017-0590-z.
4
Are professional young rugby league players eating enough? Energy intake, expenditure and balance during a pre-season.职业年轻橄榄球联盟球员的食量是否足够？一个赛季前的能量摄入、支出和平衡。
Eur J Sport Sci. 2019 Feb;19(1):123-132. doi: 10.1080/17461391.2018.1527950. Epub 2018 Oct 7.
5
Sex-Biased Physiological Roles of NPFF1R, the Canonical Receptor of RFRP-3, in Food Intake and Metabolic Homeostasis Revealed by its Congenital Ablation in mice.通过对小鼠中 NPFF1R（RFRP-3 的经典受体）的先天缺失，揭示了其在食物摄入和代谢稳态中的性别偏置生理作用。
Metabolism. 2018 Oct;87:87-97. doi: 10.1016/j.metabol.2018.07.003. Epub 2018 Jul 31.
6
Effects of the interaction of sex and food intake on the relation between energy expenditure and body composition.性别与食物摄入量的相互作用对能量消耗与身体成分之间关系的影响。
Am J Clin Nutr. 2004 Mar;79(3):385-9. doi: 10.1093/ajcn/79.3.385.
7
Energy metabolism and obesity.能量代谢与肥胖
Med Clin North Am. 2000 Mar;84(2):347-62. doi: 10.1016/s0025-7125(05)70225-x.
8
The effects of enterostatin intake on food intake and energy expenditure.摄入肠抑素对食物摄入量和能量消耗的影响。
Br J Nutr. 2003 Jul;90(1):207-14. doi: 10.1079/bjn2003871.
9
Diet composition and body composition in preschool children.学龄前儿童的饮食构成与身体组成
Am J Clin Nutr. 2000 Jul;72(1):15-21. doi: 10.1093/ajcn/72.1.15.
10
Energy-intake restriction and diet-composition effects on energy expenditure in men.能量摄入限制和饮食组成对男性能量消耗的影响。
Am J Clin Nutr. 1991 Feb;53(2):430-6. doi: 10.1093/ajcn/53.2.430.
引用本文的文献
1
Preoperative nutritional status as a predictor of postoperative overall survival in abdominal tumor surgery: a systematic review and meta-analysis.术前营养状况作为腹部肿瘤手术术后总生存的预测因素：一项系统评价和Meta分析
Front Surg. 2025 Aug 18;12:1645392. doi: 10.3389/fsurg.2025.1645392. eCollection 2025.
2
Nutritional status, body composition and chemotherapy dosing in children and young people with cancer: a systematic review by the SIOP nutrition network.癌症患儿及青少年的营养状况、身体组成与化疗剂量：国际小儿肿瘤学会营养网络的系统评价
Br J Cancer. 2025 Jun 26. doi: 10.1038/s41416-025-03023-3.
3
Sarcopenia attenuates the efficacy of PEGylated granulocyte colony-stimulating factor in preventing febrile neutropenia.肌肉减少症会削弱聚乙二醇化粒细胞集落刺激因子预防发热性中性粒细胞减少症的疗效。
Support Care Cancer. 2025 Jun 4;33(7):533. doi: 10.1007/s00520-025-09614-3.
4
Synergy of Body Composition, Exercise Oncology, and Pharmacokinetics: A Narrative Review of Personalizing Paclitaxel Treatment for Breast Cancer.身体成分、运动肿瘤学与药代动力学的协同作用：关于乳腺癌紫杉醇个体化治疗的叙述性综述
Cancers (Basel). 2025 Apr 9;17(8):1271. doi: 10.3390/cancers17081271.
5
Dose-Limiting Toxicities of Paclitaxel in Breast Cancer Patients: Studying Interactions Between Pharmacokinetics, Physical Activity, and Body Composition-A Protocol for an Observational Cohort Study.紫杉醇在乳腺癌患者中的剂量限制性毒性：研究药代动力学、身体活动与身体成分之间的相互作用——一项观察性队列研究方案
Cancers (Basel). 2024 Dec 27;17(1):50. doi: 10.3390/cancers17010050.
6
The multifactorial effect of obesity on the effectiveness and outcomes of cancer therapies.肥胖对癌症治疗效果和结果的多因素影响。
Nat Rev Endocrinol. 2024 Dec;20(12):701-714. doi: 10.1038/s41574-024-01032-5. Epub 2024 Sep 23.
7
Safety assessments and clinical features of PARP inhibitors from real-world data of Japanese patients with ovarian cancer.从日本卵巢癌患者的真实世界数据评估 PARP 抑制剂的安全性和临床特征。
Sci Rep. 2024 Jun 1;14(1):12595. doi: 10.1038/s41598-024-63600-z.
8
Challenges in identifying malnutrition in obesity; An overview of the state of the art and directions for future research.肥胖症中营养不良识别面临的挑战；最新技术综述及未来研究方向。
Nutr Res Rev. 2025 Jun;38(1):219-228. doi: 10.1017/S095442242400012X. Epub 2024 Apr 5.
9
Postoperative chemotherapy relative dose intensity and overall survival in patients with colon cancer.结肠癌患者术后化疗的相对剂量强度与总生存期。
Cancer Chemother Pharmacol. 2024 Sep;94(3):461-465. doi: 10.1007/s00280-024-04665-5. Epub 2024 Mar 23.
10
Reference ranges for body composition indices by dual energy X-ray absorptiometry from the Bone Mineral Density in Childhood Study Cohort.基于儿童期骨密度研究队列的双能 X 射线吸收法测定的人体成分指数参考范围。
Am J Clin Nutr. 2023 Oct;118(4):792-803. doi: 10.1016/j.ajcnut.2023.08.006. Epub 2023 Aug 19.
本文引用的文献
1
Dietary choices after a cancer diagnosis: A narrative review.癌症诊断后的饮食选择：一篇叙述性综述。
Nutrition. 2022 Nov-Dec;103-104:111838. doi: 10.1016/j.nut.2022.111838. Epub 2022 Sep 2.
2
Chemotherapy dosing in older adults with cancer: One size does NOT fit all.老年癌症患者的化疗剂量：一刀切并不适用。
J Geriatr Oncol. 2023 Jan;14(1):101363. doi: 10.1016/j.jgo.2022.08.012. Epub 2022 Aug 25.
3
Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracil.骨骼肌指数对氟尿嘧啶药代动力学和毒性的影响。
Cancer Med. 2023 Feb;12(3):2580-2589. doi: 10.1002/cam4.5118. Epub 2022 Aug 8.
4
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline.癌症治疗期间的运动、饮食和体重管理：ASCO 指南。
J Clin Oncol. 2022 Aug 1;40(22):2491-2507. doi: 10.1200/JCO.22.00687. Epub 2022 May 16.
5
Nutritional Preconditioning in Cancer Treatment in Relation to DNA Damage and Aging.癌症治疗中的营养预处理与DNA损伤及衰老的关系
Annu Rev Cancer Biol. 2021 Mar;5:161-179. doi: 10.1146/annurev-cancerbio-060820-090737. Epub 2020 Dec 2.
6
Energy expenditure profiles and the risk of early limiting toxicity in older patients with cancer: The ELCAPA-25 prospective cohort survey.老年癌症患者的能量消耗情况与早期限制性毒性风险：ELCAPA - 25前瞻性队列研究
Clin Nutr. 2022 May;41(5):1073-1082. doi: 10.1016/j.clnu.2022.02.016. Epub 2022 Mar 3.
7
Toxicity and efficacy of chronomodulated chemotherapy: a systematic review.时辰调节化疗的毒性与疗效：一项系统评价
Lancet Oncol. 2022 Mar;23(3):e129-e143. doi: 10.1016/S1470-2045(21)00639-2.
8
Cancer statistics, 2022.癌症统计数据，2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
9
Population pharmacokinetic analysis of crizotinib in children with progressive/recurrent high-grade and diffuse intrinsic pontine gliomas.克唑替尼在进展/复发性高级别和弥漫性内在脑桥胶质瘤患儿中的群体药代动力学分析。
Cancer Chemother Pharmacol. 2021 Dec;88(6):1009-1020. doi: 10.1007/s00280-021-04357-4. Epub 2021 Sep 29.
10
Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis.低骨骼肌量是肿瘤患者治疗相关毒性的预测因子。一项荟萃分析。
Clin Nutr. 2021 Oct;40(10):5298-5310. doi: 10.1016/j.clnu.2021.08.023. Epub 2021 Sep 3.
Zotero 插件